HCW Biologics: Maxim Group adjusts target price to $8 from $30 after 1-for-6 reverse stock split
HCWB•Maxim Group lowered its target price for HCW Biologics to $8 from $30 to reflect a 1-for-6 reverse stock split.
Related News
Jardine Matheson directors, associates acquire $36.59 million in shares via scrip dividend scheme
JMHLY•
Kardigan Inc: William Blair initiates coverage with outperform rating
KARD•
Cytokinetics initiated with outperform rating by William Blair
CYTK•
Bowman Consulting acquires geospatial AI firm dymaptic
BWMN•
Bombardier sets third-quarter results announcement
BDRBF•